{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:04:52Z","timestamp":1789592692084,"version":"build-2803163510"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Hypertrophic cardiomyopathy (HCM) is a complex disease in which left ventricular outflow tract (LVOT) obstruction influences both functional capacity and clinical outcomes. However, the clinical relevance of varying obstruction severity remains debated. To evaluate the relationship between LVOT gradient severity and both exercise performance and long-term prognosis in HCM using combined cardiopulmonary exercise testing and stress echocardiography (TTE-CPET).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We retrospectively analysed 388 HCM patients undergoing TTE-CPET, stratified into four groups based on peak LVOT gradient: &amp;lt;30 mmHg, 30\u201349 mmHg, 50\u201379 mmHg, and \u226580 mmHg. Clinical, echocardiographic, and CPET data were compared. The primary outcome was a composite of NYHA class worsening, heart failure hospitalization, new-onset atrial fibrillation, or progression to end-stage HCM, assessed over a median follow-up of 7.4 years. Only patients with severe obstruction (\u226580 mmHg, n = 82) showed significantly lower peak VO2 (15.9 vs. 19.7 mL\/kg\/min, P = 0.003), higher pulmonary pressures, more advanced diastolic dysfunction, and greater symptom burden. They also had a higher incidence of adverse events (50.0% vs. 31.6%, P = 0.011) and worse event-free survival (log-rank P = 0.011). A peak gradient \u226580 mmHg independently predicted adverse outcomes (HR: 1.87; P = 0.009), even after adjustment. Patients with intermediate gradients (30\u201379 mmHg) had generally preserved outcomes, though some exhibited early structural or functional changes<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Severe dynamic LVOT obstruction identifies a high-risk HCM subgroup with impaired exercise capacity and poor prognosis. Intermediate gradients may still warrant close monitoring. TTE-CPET offers critical insight for risk stratification and early intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjqcco\/qcag056","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:40:20Z","timestamp":1775302820000},"page":"1111-1122","source":"Crossref","is-referenced-by-count":2,"title":["Severe LVOT obstruction in HCM: effects on exercise capacity and outcomes from cardiopulmonary exercise testing combined with stress echocardiography"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7218-9891","authenticated-orcid":false,"given":"Raffaella","family":"Mistrulli","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University of Rome , Rome 00189 ,","place":["Italy"]},{"name":"Cardiovascular Center Aalst, Azorg Hospital , Aalst 9300 ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Re","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardio-Thoracic and Vascular Department, Azienda Ospedaliera San Camillo Forlanini , Cir.ne Gianicolense, Rome 87-00152 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Giacalone","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University of Rome , Rome 00189 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Storozhenko","sequence":"additional","affiliation":[{"name":"Cardiovascular Center Aalst, Azorg Hospital , Aalst 9300 ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ciacci","sequence":"additional","affiliation":[{"name":"Unit of Cardiac Sciences, Department of Medicine, Campus Bio-Medico University of Rome; Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico of Rome , Rome 00128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Di Cristo","sequence":"additional","affiliation":[{"name":"Unit of Cardiac Sciences, Department of Medicine, Campus Bio-Medico University of Rome; Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico of Rome , Rome 00128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Ferrera","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University of Rome , Rome 00189 ,","place":["Italy"]},{"name":"Institute of Sports Medicine and Science, National Italian Olympic Committee , Largo Piero Gabrielli, 1, Rome 00197 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3392-0527","authenticated-orcid":false,"given":"Domenico","family":"Gabrielli","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardio-Thoracic and Vascular Department, Azienda Ospedaliera San Camillo Forlanini , Cir.ne Gianicolense, Rome 87-00152 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7220-123X","authenticated-orcid":false,"given":"Geza","family":"Halasz","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardio-Thoracic and Vascular Department, Azienda Ospedaliera San Camillo Forlanini , Cir.ne Gianicolense, Rome 87-00152 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"2026091606033558800_qcag056-B1","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"2026091606033558800_qcag056-B2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1146\/annurev-med-042220-021539","article-title":"Hypertrophic cardiomyopathy: new concepts and therapies","volume":"73","author":"Maron","year":"2022","journal-title":"Annu Rev Med"},{"key":"2026091606033558800_qcag056-B3","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1253\/circj.CJ-16-0432","article-title":"Heart failure progression in hypertrophic cardiomyopathy- possible insights from cardiopulmonary exercise testing","volume":"80","author":"Magr\u00ec","year":"2016","journal-title":"Circ J"},{"key":"2026091606033558800_qcag056-B4","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N Engl J Med"},{"key":"2026091606033558800_qcag056-B5","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.ahj.2009.06.006","article-title":"Mechanisms of exercise intolerance in patients with hypertrophic cardiomyopathy","volume":"158","author":"Le","year":"2009","journal-title":"Am Heart J"},{"key":"2026091606033558800_qcag056-B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12574-012-0150-0","article-title":"Early diastolic function during exertion influences exercise intolerance in patients with hypertrophic cardiomyopathy","volume":"11","author":"Mizukoshi","year":"2013","journal-title":"J Echocardiogr"},{"key":"2026091606033558800_qcag056-B7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jacc.2021.12.002","article-title":"Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC state-of-the-art review","volume":"79","author":"Maron","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026091606033558800_qcag056-B8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijcard.2019.04.053","article-title":"How to perform and report a cardiopulmonary exercise test in patients with chronic heart failure","volume":"288","author":"Agostoni","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026091606033558800_qcag056-B9","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/eurheartj\/ehw180","article-title":"2016 focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations","volume":"39","author":"Guazzi","year":"2018","journal-title":"Eur Heart J"},{"key":"2026091606033558800_qcag056-B10","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/ehjci\/jew190","article-title":"The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European association of cardiovascular imaging and the American society of echocardiography","volume":"17","author":"Lancellotti","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026091606033558800_qcag056-B11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026091606033558800_qcag056-B12","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/ehf2.14776","article-title":"Exercise limitation in hypertrophic cardiomyopathy: combined stress echocardiography and cardiopulmonary exercise test","volume":"11","author":"Erez","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2026091606033558800_qcag056-B13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ejhf.3120","article-title":"Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population","volume":"26","author":"Bertero","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026091606033558800_qcag056-B14","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.amjcard.2010.06.057","article-title":"Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy","volume":"106","author":"Nistri","year":"2010","journal-title":"Am J Cardiol"},{"key":"2026091606033558800_qcag056-B15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ijcard.2016.10.067","article-title":"Dissecting functional impairment in hypertrophic cardiomyopathy by dynamic assessment of diastolic reserve and outflow obstruction: a combined cardiopulmonary-echocardiographic study","volume":"227","author":"Re","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026091606033558800_qcag056-B16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijcard.2018.07.110","article-title":"Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death","volume":"274","author":"Smith","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026091606033558800_qcag056-B17","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.3390\/jcm10112312","article-title":"Cardiopulmonary exercise test in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"10","author":"Bayonas-Ruiz","year":"2021","journal-title":"J Clin Med"},{"key":"2026091606033558800_qcag056-B18","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1136\/heartjnl-2021-320569","article-title":"Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy","volume":"108","author":"Mapelli","year":"2022","journal-title":"Heart"},{"key":"2026091606033558800_qcag056-B19","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1161\/01.cir.92.10.2886","article-title":"Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics","volume":"92","author":"Lele","year":"1995","journal-title":"Circulation"},{"key":"2026091606033558800_qcag056-B20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/jcm7110447","article-title":"Predictors of exercise capacity in patients with hypertrophic obstructive cardiomyopathy","volume":"7","author":"Smith","year":"2018","journal-title":"J Clin Med"},{"key":"2026091606033558800_qcag056-B21","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/ehjci\/jeaf238","article-title":"Hypercontractile phenotype in hypertrophic cardiomyopathy indicates unfavorable hemodynamics, coronary flow and prognosis","volume":"26","author":"Wierzbowska-Drabik","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026091606033558800_qcag056-B22","doi-asserted-by":"publisher","first-page":"1620313","DOI":"10.3389\/fcvm.2025.1620313","article-title":"Atrial remodelling and dysfunction in hypertrophic cardiomyopathy: prognostic role and therapeutic target","volume":"12","author":"Piazzai","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"2026091606033558800_qcag056-B23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.amjcard.2025.06.026","article-title":"Atrial fibrillation catheter ablation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"254","author":"Stabile","year":"2025","journal-title":"Am J Cardiol"},{"key":"2026091606033558800_qcag056-B24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.21037\/cdt.2016.11.23","article-title":"Outcomes in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a survival meta-analysis","volume":"7","author":"Masri","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"2026091606033558800_qcag056-B25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"2026091606033558800_qcag056-B26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1001\/jamacardio.2022.5099","article-title":"Effects of mavacamten on measures of cardiopulmonary exercise testing beyond peak oxygen consumption: a secondary analysis of the EXPLORER-HCM randomized trial","volume":"8","author":"Wheeler","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2026091606033558800_qcag056-B27","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3390\/medicina59071296","article-title":"The role of cardiopulmonary exercise testing in hypertrophic cardiomyopathy","volume":"59","author":"Mikic","year":"2023","journal-title":"Medicina (Kaunas)"}],"container-title":["European Heart Journal - Quality of Care and Clinical Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article-pdf\/doi\/10.1093\/ehjqcco\/qcag056\/67871450\/qcag056.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/12\/6\/1111\/67871450\/qcag056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/12\/6\/1111\/67871450\/qcag056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:03:44Z","timestamp":1789553024000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article\/12\/6\/1111\/8607777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,4,6]]},"published-print":{"date-parts":[[2026,9,16]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjqcco\/qcag056","relation":{},"ISSN":["2058-5225","2058-1742"],"issn-type":[{"value":"2058-5225","type":"print"},{"value":"2058-1742","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,4,6]]}}}